Stocks · News reference

Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32

Aug 14, 2026, 12:52 PMBenzinga Newsdesk

Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $27 to $32.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Fiscal.aiOct 23, 2026, 9:32 PM
PRISM MarketView Highlights Omada Health for National Physical Therapy Month
Omada Health was featured in a PRISM MarketView report highlighting public companies contributing to strength, mobility, and chronic disease management during National Physical Therapy Month.
OMDA
Fiscal.aiOct 21, 2026, 9:32 PM
Omada Health to Present Peer-Reviewed Research on GLP-1 Treatment at World Obesity and Weight Management Congress
Omada Health announced it will present new peer-reviewed research regarding weight loss and body composition outcomes for patients undergoing GLP-1 treatment.
OMDA
BenzingaOct 20, 2026, 1:02 PMBenzinga Newsdesk
Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care
OMDA
BenzingaOct 12, 2026, 9:18 AMBenzinga Insights
Transcript: Omada Health Q2 2026 Earnings Conference Call
Omada Health (NASDAQ:OMDA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
OMDA